USPTO serial 79275300
Serial No. 79275300
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 27, 2020
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79275300?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $850
Owner
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Chinhwei Chen
Chinhwei Chen Jianq Chyun Intellectual Property Office7F.-1, No. 100, Roosevelt Rd. Sec. 2Taipei, 10084TAIWANGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Herbal teas for medicinal purposes; Medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Nutritive substance for microorganisms for medical purposes; Capsules sold empty for medicines; Medicinal herbal tea; Chinese patent medicines for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Injectable solutions for medical purposes for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; diet teas for medical purpose; medicated liquor; disinfectants; powdered milk for babies; dietetic substances adapted for medical use; air purifying preparations; Medicines for veterinary purposes for treating antimicrobial and anti-parasitic treatment, for promoting growth of animals and for the treatment of nervous, gastrointestinal, respiratory and metabolic system related diseases; vermin destroying preparations; mosquito-repellent incenses; preparations for destroying noxious animals; adhesive tapes for medical purposes; tissues impregnated with pharmaceutical lotions; teeth filling material; medicinal drinks; Pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Decoctions for pharmaceutical purpose for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; digestives for pharmaceutical purposes; Active pharmaceutical ingredients, namely, pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Radioactive pharmaceuticals for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; solutions for contact lenses; media for bacteriological cultures; candy, medicated; chewing gum for medical purposes | ACTIVE | — |
| 030 | Cocoa preparations, namely, cocoa, cocoa powder; tea-based beverages; tea substitutes; sugar; ginseng candy; herbal jelly candy; instant edible bird's nest with sugar; loquat paste being fruit paste for flavoring food; confectionery, namely, candy; cooking salt; yeast; food flavorings being non-essential oils in the nature of citrus, fruit, mint, bean, spicy, milk flavor, meat flavor, nut, wine and vegetable essences for foodstuffs, except etheric essences and essential oils; vegetal preparations for use as coffee substitutes; tea; peppermint sweets; royal jelly for food purposes; breakfast cereal consisting of dried fruit and nuts; Processed cereal powder-based food; cereal preparations, namely, cereal bars; noodle-based prepared meals; cereal-based snack food; bean flour; starch for food; edible ices; vinegar; seasonings; gluten prepared as foodstuff for culinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 030
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 23, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 9, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 9, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 27, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 8, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 27, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 7, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 22, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 22, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 16, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 16, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 16, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 14, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |